Your steadfast partner on the clinical trial journey

We have the experience, scale and reach to support you successfully from discovery through CDx Development.

CLIA Certified

We are Sysmex Inostics, a CLIA certified lab based in Baltimore, MD, and a pioneering leader in the liquid biopsy revolution.

We offer a superior customer service experience

Comprehensive testing solutions
Project management support
Companion Dx development
Comprehensive testing solutions
Project management support
Companion Dx development

Explore an extensive portfolio of cfDNA and cfRNA NGS services for drug discovery, therapy selection and treatment response monitoring.

Discover exceptional project management with seamless end-to-end solutions without any compromises or complexities throughout your clinical trial process.

Accelerate global CDx development through our partnership with QIAGEN®.

Comprehensive testing solutions
Comprehensive testing solutions

Explore an extensive portfolio of cfDNA and cfRNA NGS services for drug discovery, therapy selection and treatment response monitoring.

Project Management
Project management support

Discover exceptional project management with seamless end-to-end solutions without any compromises or complexities throughout your clinical trial process.

Companion Dx Development
Companion Dx development

Accelerate global CDx development through our partnership with QIAGEN®.

Discovery and monitoring

Our broad portfolio of molecular assays yields informative data from cfDNA and cfRNA samples to aid in your therapy development.

Phase I
Phase II
Phase III
Phase IV
Broad Panel
200+ gene targets sequenced to 20,000X read depth

Large cfDNA & cfRNA enrichment library to identify novel biomarkers

Investigate the genomic landscape for TMB, HRD and MSI

Utilize tissue-informed solutions for comprehensive variant monitoring

Targeted Panel
≤ 30 gene targets sequenced to 1mil X read depth

Greater sequencing depth to allow for higher sensitivity and specificity

Tumor agnostic approach optimized for detection of ultra-low frequency mutations

Simplified data analysis and assays designed to meet the needs of clinical intended use

dPCR
≤ 5 targets

Highly sensitive approach for 1 – 5 targets

Minimal sample prep and faster results (within hours)

Ability to monitor response to treatment or patient stratification

CDx development

We teamed up with QIAGEN to accelerate global CDx development. Our collective expertise allows us to anticipate and understand your specific needs throughout the clinical trial process.

Accelerating the pace of drug discovery & development

As a trusted partner in clinical trial solutions, we are accelerating the pace of drug discovery and development, enabling new treatment alternatives and renewed hope for cancer patients. Let us help you achieve a successful clinical trial.

Supporting biopharma with the clinical trial process

We are fully committed to providing unwavering support to our biopharma clients at every stage of the clinical trial process. Our aim is to deliver seamless end-to-end solutions without any compromises or unnecessary complexities. Our extensive portfolio includes a wide range of cfDNA and cfRNA NGS services, all backed by an exceptional project management team that sets us apart.